Compliance & Oversight
Expert articles and analysis related to compliance & oversight.
AI Summary — Last 7 Days
Over the past week, significant compliance issues have emerged, particularly with CMS's decision to halt enrollment in Elevance’s Medicare Advantage plans due to "substantial and persistent noncompliance" in reporting customer information, further underscoring the need for strict adherence to regulations in the Medicare landscape. Additionally, the Office of Inspector General (OIG) identified $285.2 million in improper payments related to autism therapy in Colorado, reflecting ongoing scrutiny about payment integrity and quality of care in Medicaid programs. These developments signal an increasing focus on oversight and compliance as key dynamics shaping the strategies of health systems and ACOs in a regulatory environment marked by heightened vigilance and accountability, potentially impacting funding and care delivery models. For more details, see the coverage on CMS halting Elevance enrollment and HHS's audit on autism therapy payments.
Related Articles
6 Texas physicians to pay $5M to settle false claims allegations
Six South Texas physicians and their practices agreed to pay $4.9 million to resolve allegations they submitted false claims to Medicare, Medicaid and TriCare for services that were not rendered or no...
The Conduent Breach: A Stewardship Failure at Scale
EDITOR’S NOTE: The author of this article used AI-assisted tools in its composition, but all content, analysis, and conclusions were based on the author’s professional judgment and expertise. The arti...
STAT+: Federal Medicaid audit finds massive overpayment for autism therapy in Colorado
HHS's OIG uncovered $285.2 million in improper and potentially improper payments to clinicians of an autism therapy called applied behavior analysis, it said.
General Question for the Week of March 2, 2026
When it comes to oversight, what is the AMA's stance on artificial intelligence (AI)?
The hidden toll of physician regulatory investigations
I have spent my career believing in systems. As physicians, we are trained to trust oversight. We are taught that regulatory bodies exist to protect patients, maintain standards, and intervene when ca...
CMS announces pause on new durable medical equipment suppliers
The Trump administration issued a nationwide moratorium on new suppliers for certain medical equipment, citing fraud.
How AI Can Both Detect and Enable Fraudulent Research – The Monitor
A new study finds that nearly 10% of cancer research papers showed signs of being fabricated by “paper mills”. The problem may intensify as generative AI becomes more sophisticated, prompting lawmaker...
Medical ethics and AI: Why losing oversight endangers patients
At the end of December 2025, the American Medical Association (AMA) Journal of Ethics ceased its operations, now just a relic of the past. Its inception began in September 1999 with a journal theme en...
STAT+: Pharmalittle: We’re reading about a puzzling FDA rejection, a Lilly weight loss pill, and more
An experimental therapy for a rare blood cancer was rejected by the FDA though internal reviewers had recommended it be cleared
STAT+: Rare disease advocates fume over FDA’s mixed signals
Families facing rare diseases feel whiplash over shifting and contradictory decisions by the FDA.